SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas

por Zhu, Eliot Y., Riordan, Jesse D., Vanneste, Marion, Henry, Michael D., Stipp, Christopher S., Dupuy, Adam J.
Publicado 2022

Quantification of capture efficiency, purity, and single-cell isolation in the recovery of circulating melanoma cells from peripheral blood by dielectrophoresis

por Chen, Han, Osman, Sommer Y., Moose, Devon L., Vanneste, Marion, Anderson, Jared L., Henry, Michael D., Anand, Robbyn K.
Publicado 2023

High content screening identifies monensin as an EMT-selective cytotoxic compound

por Vanneste, Marion, Huang, Qin, Li, Mengshi, Moose, Devon, Zhao, Lei, Stamnes, Mark A., Schultz, Michael, Wu, Meng, Henry, Michael D.
Publicado 2019

The anti-cancer efficacy of a novel phenothiazine derivative is independent of dopamine and serotonin receptor inhibition

por Vanneste, Marion, Venzke, Anita, Guin, Soumitra, Fuller, Andrew J., Jezewski, Andrew J., Beattie, Sarah R., Krysan, Damian J., Meyers, Marvin J., Henry, Michael D.
Publicado 2023

Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study

por Zakharia, Yousef, Monga, Varun, Swami, Umang, Bossler, Aaron D., Freesmeier, Michele, Frees, Melanie, Khan, Mirza, Frydenlund, Noah, Srikantha, Rithu, Vanneste, Marion, Henry, Michael, Milhem, Mohammed
Publicado 2017

Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging

por Yong, Courtney, Moose, Devon L., Bannick, Nadine, Gutierrez, Wade R., Vanneste, Marion, Svensson, Robert, Breheny, Patrick, Brown, James A., Dodd, Rebecca D., Cohen, Michael B., Henry, Michael D.
Publicado 2020

Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy

por Rieth, John M., Swami, Umang, Mott, Sarah L., Zanaty, Mario, Henry, Michael D., Bossler, Aaron D., Greenlee, Jeremy D., Zakharia, Yousef, Vanneste, Marion, Jennings, Brooke, Milhem, Mohammed M.
Publicado 2021

Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis

por Vanneste, Marion, Feddersen, Charlotte R., Varzavand, Afshin, Zhu, Elliot Y., Foley, Tyler, Zhao, Lei, Holt, Kathleen H., Milhem, Mohammed, Piper, Robert, Stipp, Christopher S., Dupuy, Adam J., Henry, Michael D.
Publicado 2020